31 Oct 2025 | 3 Mins Read
Dr Lal PathLabs Q2 Results: Profit up 16%, ₹152 crore
Flipitmoney
Dr Lal PathLabs reported a 10.7% revenue increase to ₹731 crore in Q2 FY26, part of an 11.0% rise in the first half to ₹1,400 crore. EBITDA rose 10.8% with a 30.7% margin, while PAT increased 16.4% to ₹152 crore with a 20.8% margin. The company declared an interim dividend of ₹7 per share and approved a 1:1 bonus issue.